We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

DIESSE DIAGNOSTICA SENESE SPA

DIESSE Diagnostica Senese S.P.A. manufactures in-vitro diagnostics systems for the hematology, seroimmunology and bac... read more Featured Products: More products

Download Mobile App





DIESSE Diagnostica Demonstrates Advanced Immunoassay and ESR Analyzers at EUROMEDLAB 2022

By LabMedica International staff writers
Posted on 12 Apr 2022
Print article
Image: The CHORUS TRIO and VES MATIC 5 presented at EUROMEDLAB (Photo courtesy of Diesse Diagnostica)
Image: The CHORUS TRIO and VES MATIC 5 presented at EUROMEDLAB (Photo courtesy of Diesse Diagnostica)

Diesse Diagnostica Senese S.p.A. (Rigoni, Italy) demonstrated its CHORUS TRIO and VES MATIC 5 instruments at EUROMEDLAB 2022 which was held 10th-14th April 2022 in Munich, Germany.

CHORUS TRIO is an easy-to-use single test multiparametric system for immunometric assay. The single test device contains all the reagents necessary to perform the assay, thus eliminating hidden costs or waste of reagents. Ease of use and the most expansive selection of tests available on the market (infectious diseases, autoimmunity, endocrinology, and tumor markers, allergy, bone metabolism, inflammation) make it the ideal tool for performing small series diagnostic tests while ensuring maximum flexibility in organizing the clinical laboratory’s workflow. From the smallest to the largest, CHORUS TRIO easily adapts to the needs of any clinical analysis laboratory.

At EUROMEDLAB 2022, Diesse Diagnostica also demonstrated its new VES MATIC 5 automatic instrument for the determination of the ESR directly on the hematocrit tube (190 samples/hour), using racks from the main cell counters. ESR is a valuable laboratory test in a range of clinical conditions, such as rheumatoid diseases, orthopedic infections and Hodgkin’s lymphoma, and it can be used for the follow‐up of infectious, inflammatory, malignant and autoimmune diseases. Featuring IoT with internal cameras for advanced remote assistance, along with a modern and interactive graphic user interface, VES MATIC 5 offers continuous and random access loading of any kind of cell counter racks. Diesse Diagnostica plans to soon enable VES MATIC 5 to provide artificial intelligence-based recognition of lipemic, hemolyzed, coagulated and mislabeled samples.

Related Links:
Diesse Diagnostica Senese Spa 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.